José Miguel Vela Selected Research

3,N- dimethyl- N- (1- methyl- 3- (4- methylpiperidin- 1- yl)propyl)benzenesulfonamide

6/2010	Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity.
2/2009	5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José Miguel Vela Research Topics

Disease

26	Pain (Aches) 12/2022 - 02/2009
10	Neuralgia (Stump Neuralgia) 04/2022 - 07/2008
5	Hyperalgesia 08/2018 - 07/2008
5	Hypersensitivity (Allergy) 04/2016 - 02/2009
3	Acute Pain 01/2019 - 01/2015
2	Inflammation (Inflammations) 05/2022 - 01/2016
2	Chronic Pain 04/2022 - 01/2015
2	Visceral Pain 01/2017 - 01/2015
1	Osteoarthritis 05/2022
1	Constipation 12/2020
1	COVID-19 01/2020
1	Severe Acute Respiratory Syndrome 01/2020
1	Nociceptive Pain 01/2019
1	Postoperative Pain 08/2018
1	Necrosis 01/2018
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2018
1	Diabetic Neuropathies (Diabetic Neuropathy) 04/2016
1	Polyneuropathies (Polyneuropathy) 04/2016
1	Mydriasis 07/2013
1	Painful Neuropathy 11/2012
1	Dementia (Dementias) 05/2004
1	Schizophrenia (Dementia Praecox) 05/2004
1	Multiple Sclerosis 04/2003

Drug/Important Bio-Agent (IBA)

10	Sigma-1 ReceptorIBA 04/2022 - 07/2013
8	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2012
6	LigandsIBA 01/2020 - 02/2009
4	Opioid Analgesics (Opioids)IBA 01/2019 - 07/2013
4	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 07/2013
4	Formaldehyde (Formol)FDA Link 05/2014 - 01/2012
3	Oxycodone (Oxycontin)FDA LinkGeneric 01/2021 - 08/2018
3	Capsaicin (Zostrix)FDA Link 05/2013 - 02/2009
2	Pregabalin (Lyrica)FDA Link 12/2022 - 04/2016
2	Pharmaceutical PreparationsIBA 04/2022 - 01/2020
2	Opioid Receptors (Opioid Receptor)IBA 01/2021 - 12/2020
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018 - 11/2012
2	Ion Channels (Ion Channel)IBA 01/2017 - 01/2017
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016 - 05/2014
2	PlasticsIBA 01/2016 - 01/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2012 - 07/2008
2	AcetoneIBA 11/2012 - 07/2008
2	3,N- dimethyl- N- (1- methyl- 3- (4- methylpiperidin- 1- yl)propyl)benzenesulfonamideIBA 06/2010 - 02/2009
1	Saline SolutionIBA 12/2022
1	Reserpine (Serpasil)FDA Link 12/2022
1	AcidsIBA 12/2022
1	enflicoxibIBA 05/2022
1	TriazolesIBA 01/2021
1	propionamideIBA 01/2021
1	EST64454IBA 12/2020
1	PyrazolesIBA 12/2020
1	undecaneIBA 12/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Tramadol (K315)FDA LinkGeneric 08/2018
1	SuspensionsIBA 08/2018
1	Acetaminophen (Paracetamol)FDA LinkGeneric 08/2018
1	Drug CombinationsIBA 08/2018
1	Celecoxib (Celebrex)FDA Link 08/2018
1	InterleukinsIBA 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	CytokinesIBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 04/2016
1	Gabapentin (Neurontin)FDA LinkGeneric 04/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2016
1	4- (2- ((5- methyl- 1- (2- naphthalenyl)- 1H- pyrazol- 3- yl)oxy)ethyl)morpholineIBA 04/2016
1	mu Opioid Receptors (mu Opioid Receptor)IBA 04/2015
1	Caffeine (No Doz)FDA LinkGeneric 01/2015
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2015
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2015
1	SaccharinIBA 01/2015
1	Therapeutic UsesIBA 09/2013
1	Molecular Chaperones (Chaperone, Molecular)IBA 07/2013
1	1- (2- (3,4- dichlorophenyl)ethyl)- 4- methylpiperazineIBA 11/2012
1	morpholineIBA 10/2012
1	Glutamic Acid (Glutamate)FDA Link 01/2012
1	salicylhydroxamic acid (SHAM)IBA 06/2010
1	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 02/2009
1	befiradolIBA 02/2009
1	SB 269970IBA 02/2009
1	serotonin 7 receptorIBA 02/2009
1	Antineoplastic Agents (Antineoplastics)IBA 07/2008
1	Tetrodotoxin (Tetradotoxin)IBA 07/2008
1	Sodium Channels (Sodium Channel)IBA 07/2008
1	Psychotropic Drugs (Psychoactive Drugs)IBA 05/2004
1	CannabinoidsIBA 04/2003

Therapy/Procedure

3	Ligation 04/2022 - 10/2009
3	Therapeutics 01/2020 - 09/2013
2	Analgesia 01/2019 - 01/2015
2	Drug Therapy (Chemotherapy) 11/2012 - 07/2008
1	Injections 12/2022